Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Power and sample-size estimation in human microbiome research.

Med (New York, N.Y.)·2026
Same author

Graft-Assisted Transapical Transcatheter Aortic Valve Replacement with Concomitant Robotic Minimally Invasive Direct Coronary Artery Bypass.

The Annals of thoracic surgery·2026
Same author

Hypoxia Induces Adaptive Lymphangiogenesis via Cd74 and Vegfr3 to Modulate Pulmonary Hypertension.

Circulation research·2026
Same author

CES1 deficiency is associated with metabolic reprograming and endothelial dysfunction in pulmonary arterial hypertension.

American journal of respiratory and critical care medicine·2026
Same author

Correction to: Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary Hypertension.

Circulation research·2026
Same author

Microbiome-Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed?

Research (Washington, D.C.)·2025

Related Experiment Video

Updated: Jul 15, 2026

Orthotopic Left Lung Transplantation in Rats
08:22

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

The matrix comes to lung transplantation.

Ashok N Babu1, Mark R Nicolls

  • 1Department of Surgery, University of Colorado Health Sciences Center, Denver, CO 80262, USA.

Transplantation
|April 7, 2007
PubMed
Summary

Matrix metalloproteinases (MMPs) and their inhibitors are key players in lung transplant fibrosis. A new study reveals their complex roles in immune responses following lung transplants.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Translational Research

Background:

  • Lung transplantation is susceptible to fibroproliferation, a significant complication.
  • Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) are implicated in fibrotic processes.

Discussion:

  • This commentary reviews the known roles of MMPs and TIMPs in fibrotic lung diseases.
  • It highlights a new study by Yoshida et al. investigating these mediators in lung transplant alloimmune inflammation.

Key Insights:

  • MMPs and TIMPs exhibit diverse functions beyond matrix degradation.
  • Their involvement in alloimmune responses is crucial for understanding post-transplant complications.

Outlook:

  • Further research into MMP/TIMP pathways could lead to novel therapeutic strategies.

More Related Videos

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

Related Experiment Videos

Last Updated: Jul 15, 2026

Orthotopic Left Lung Transplantation in Rats
08:22

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

  • Targeting these mediators may mitigate fibroproliferation and improve lung transplant outcomes.